Dr Richard C.A. Sainson

Other
Kymab Ltd

Position: Senior Director Translational Medicine
Personal home page: https://www.linkedin.com/in/richard-c-a-sainson-6ba312a

PubMed journal articles - click here

Research description

I have 20 years of oncology research experience acquired both in academia (UC Irvine, USA and University of Oxford, UK) and industry (Kymab, Medimmune/AZ and Astex) where he was the scientific lead for antiangiogenic and immuno-oncology programs. He has broad expertise in multiple fields of cancer biology including cancer immunology, tumour microenvironment biology and cell signalling. Within Kymab, his current role involves leading the translational medicine/biomarker efforts for late stage projects, including Kymab’s most advanced immuno-oncology program, KY1044 (anti-ICOS) program. Richard received an MSc in Cellular and Molecular Biology from the University of Paris VI, France and a PhD in Biochemistry from the University of Leeds, UK.

Research Programme
Onco-Innovation
Keywords

Immuno-oncology
Tumour stroma
angiogenesis
immune cells
cancer fibroblast
cell signalling
in vivo
immunotherapy
translational